Brief: Cosmos Health To Start US Production At GMP-Certified Facilities
24/06/2025 16:16
June 24 (Reuters) - Cosmos Health Inc COSM.O: COSMOS HEALTH ENTERS U.S. MARKET WITH STRATEGIC MADE-IN-AMERICA MANUFACTURING, MITIGATING TARIFF RISKS; EXECUTES AGREEMENT WITH NEW JERSEY-BASED DOLCAS BIOTECH COSMOS HEALTH INC - TO START U.S. PRODUCTION AT GMP-CERTIFIED FACILITIES ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cosmos Health
See all newsCosmos Health Q3 revenue rises to record high on contract manufacturing
Brief: Cosmos Health Secures Additional 2.5 Mln Units Under New Five-Year Contract Manufacturing Deal With Viofar
Brief: Cosmos Health Reaffirms 2029 Guidance
Brief: Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Deal With Innova Healthcare
Brief: Cosmos Health Reports Q2 2026